← Back to Clinical Trials
Recruiting NCT05550064

NCT05550064 Structured Contraceptive Counseling During Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05550064
Status Recruiting
Phase
Sponsor Dalarna University
Condition Contraception
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2022-11-19
Primary Completion 2025-06-19

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Structured contraceptive counseling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2022-11-19 with a primary completion date of 2025-06-19.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Unintended pregnancy is common among women of fertile age, and also among those who have recently given birth. A Swedish study has shown that about 7.7% experience a new pregnancy, and that 2.5% will have an abortion between 12-24 months from childbirth. This is a prospective observational intervention study, aiming to evaluate the effects of structured contraceptive counseling during pregnancy on uptake of contraception postpartum and more specifically on long-acting reversible contraceptive methods, and to identify and explore the provider's and patient's experiences of structured contraceptive counseling during pregnancy.

Eligibility Criteria

Inclusion Criteria: * 18 years or older, gestational week 30 or more, need for contraception 6 months or more after delivery Exclusion Criteria: \- Language barrier that affects participation when an interpreter is not available, assisted fertilization, planned sterilization of partner, use of contraception for other purposes than pregnancy prevention.

Contact & Investigator

Central Contact

Niklas Envall, PhD

✉ nen@du.se

📞 +46704090925

Principal Investigator

Niklas Envall, PhD

PRINCIPAL INVESTIGATOR

Dalarna University

Frequently Asked Questions

Who can join the NCT05550064 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05550064 currently recruiting?

Yes, NCT05550064 is actively recruiting participants. Contact the research team at nen@du.se for enrollment information.

Where is the NCT05550064 trial being conducted?

This trial is being conducted at Falun, Sweden, Karlstad, Sweden, Örebro, Sweden, Uppsala, Sweden.

Who is sponsoring the NCT05550064 clinical trial?

NCT05550064 is sponsored by Dalarna University. The principal investigator is Niklas Envall, PhD at Dalarna University. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology